Efficient use and recycling of the micronutrient iodide in mammals

Biochimie

Volumn 92, Issue 9, 2010, Pages 1227-1235

  Rokita, Steven E ^a   Adler, Jennifer M ^a   McTamney, Patrick M ^a   Watson, James A ^a  

^a University of Maryland   (United States)

Author keywords

Deiodinase; Flavoprotein; Iodide metabolism; Reductive dehalogenation; Thyroid

Indexed keywords

CYSTEINE; IODIDE; IODOTYROSINE;

CRYSTALLOGRAPHY; DEHALOGENATION; ENZYME ACTIVITY; HORMONE SYNTHESIS; HUMAN; MUTAGENESIS; NONHUMAN; PURIFICATION; REVIEW; THYROID GLAND;

ANIMALS; HUMANS; IODIDE PEROXIDASE; IODIDES; MICRONUTRIENTS; MUTAGENESIS, SITE-DIRECTED; THYROID GLAND;

MAMMALIA;

EID: 77955841663     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2010.02.013     Document Type: Review

References (72)

1. http://www.who.int/nutrition/topics/idd/en/index.html.
2. Zimmermann M.B., Jooste P.L., Pandav C.S. Iodine-deficiency disorders. Lancet 2008, 372:1251-1262.
3. Johnson K.S., Coale K.H., Jannasch J.W. Analytical chemistry in oceanography. Anal. Chem. 1992, 64:1065-1075.
4. Stanbury J.B., Meijer J.W.A., Kassenaar A.A.H. The metabolism of iodotyrosines. II. The metabolism of mono and diiodotyrosine in certain patients with familial goiter. J. Clin. Endocrinol. Metab. 1956, 16:848-868.
5. Dohán O., de la Vieja A., Paroder V., Riedel C., Artani M., Reed M., Ginter C.S., Carrasco N. The sodium/iodide symporter (NIS); characterization, regulation and medical significance. Endocr. Rev. 2003, 24:48-77.
6. Moreno J.C., Klootwijk W., van Toor H., Pinto G., D'Alessandro M., Lèger A., Goudie D., Polak M., Grüters A., Visser T.J. Mutations in the iodotyrosine deiodinase gene and hypothyroidism. N. Engl. J. Med. 2008, 358:1811-1818.
7. Afink G., Kulik W., Overmars H., de Randamie J., Veenboer T., van Cruchten A., Craen M., Ris-Stalpers C. Molecular characterization of iodotyrosine dehalogenase deficiency in patients with hypothyroidism. J. Clin. Endocrinol. Metab. 2008, 93:4894-4901.
8. Burrows G.N., Oppenheimer J.H., Volpé R. Thyroid Function and Disease 1989, Saunders, Philadelphia.
9. Bizhanova A., Kopp P. The sodium-iodide symporter NIS and pendrin in iodide homeostasis of the thyroid. Endocrinology 2009, 150:1084-1090.
10. DeGroot L.J., Laarse P.R., Refetoff S., Stanbury J.B. The Thyroid and its Diseases 1984, Wiley & Sons, New York, (Chapter 1).
11. Bianco A.C., Salvatore D., Gereben B., Berry M.J., Larsen P.R. Biochemistry, cellular and molecular biology and physiological roles of the iodothyronine selenodeiodinases. Endocr. Rev. 2002, 23:38-89.
12. St.Germain D.L., Galton V.A., Hernandez A. Minireview: defining the roles of the iodothyronine deiodinases: current concepts and challenges. Endocrinology 2009, 150:1097-1107.
13. Callebaut I., Curcio-Morelli C., Mornon J.-P., Gereben B., Buettner C., Huang S., Castro B., Fonseca T.L., Harney J.W., Larsen P.R., Bianco A.C. The iodothyronine selenodeiodinases are thioredoxin-fold family proteins containing a glycoside hydrolase clan GH-A-like structure. J. Biol. Chem. 2003, 278:36887-36896.
14. Berry M.J., Banu L., Larsen P.R. Type I iodothyronine deiodinase is a selenocysteine-containing enzyme. Nature 1991, 349:438-440.
15. Berry M.J., Kieffer J.D., Harney J.W., Larsen P.R. Selenocysteine confers the biochemical properties characteristic of the type I iodothyronine deiodinase. J. Biol. Chem. 1991, 266:14155-14158.
16. Berry M.J., Banu L., Che Y., Mandel S.J., Kieffer J.D., Harney J.W., Larsen P.R. Recognition of a UGA as a selenocysteine codon in type 1 deiodinase requires sequences in the 3' untranslated region. Nature 1991, 353:273-276.
17. Larsen P.R. Update on the human iodothyronine selenodeiodinases, the enzymes regulating activation and inactivation of thyroid hormone. Biochem. Soc. Trans. 1997, 25:588-592.
18. Vasil'ev A.A., Engman L. Iodothyronine deiodinase mimics. Deiodination of o, o'-diiodophenols by selenium and tellurium reagents. J. Org. Chem. 1998, 63:3911-3917.
19. McNabb F.M.A. Thyroid Hormones 1992, Prentice Hall, Englewood Cliffs, (Chapter 3).
20. Gnidehou S., Caillou B., Talbot M., Ohayon R., Kaniewski J., Noël-Hudson M.-S., Morand S., Agnangji D., Sezan A., Courtin F., Virion A., Dupuy C. Iodotyrosine dehalogenase 1 (DEHAL1) is a transmembrane protein involved in the recycling of iodide close to the thyroglobulin iodination site. FASEB J. 2004, 18:1574-1576.
21. Friedman J.E., Watson J.A., Lam D.W.-H., Rokita S.E. Iodotyrosine deiodinase is the firs t mammalian member of the NADH oxidase/flavin reductase superfamily. J. Biol. Chem. 2006, 281:2812-2819.
22. Rosenberg I.N., Goswami A. Iodotyrosine deiodinase from bovine thyroid. Methods Enzymol. 1984, 107:488-500.
23. Hartmann N. Über den Abbau von Dijotyrosin im Gewebe. Z. Physiol. Chem. 1950, 285:1-17.
24. Roche J., Michel O., Michel R., Gorbman A., Lissitzky S. Sur la deshalogénation enzymatique des iodotyrosines par le corps thyroïde et sur son rôle physiologique. II. Biochim. Biophys. Acta 1953, 12:570-576.
25. Solis-S J.C., Villalobos P., Valverde-R C. Comparative kinetic characterization of rat thyroid iodotyrosine dehalogenase and iodothyronine deiodinase type 1. J. Endocrinol. 2004, 181:385-392.
26. Stanbury J.B., Kassenaar A.A.H., Meijer J.W.A., Terpstra J. The occurrence of mono- and diiodotyrosine in the blood of a patient with congential goiter. J. Clin. Endocrinol. Metab. 1955, 15:1216-1227.
27. Stanbury J.B., Kassenaar A.A.H., Meijer J.W.A. The metabolism of iodotyrosines. I. The fate of mono- and diiodotyrosine in normal subjects and in patients with various diseases. J. Clin. Endocrinol. Metab. 1956, 16:735-746.
28. Lever E.G., Medeiros-Neto G.A., DeGroot L.J. Inherited disorders of thyroid metabolism. Endocr. Rev. 1983, 4:213-239.
29. Stanbury J.B. The requirement of monoiodotyrosine deiodinase for triphosphopyridine nucleotide. J. Biol. Chem. 1957, 228:801-811.
30. Stanbury J.B., Morris M.L. Deiodination of diiodotyrosine by cell-free systems. J. Biol. Chem. 1958, 233:106-108.
31. Matsuzaki S., Suzuki M. Deiodination of iodinated amino acids by pig thyroid microsomes. J. Biochem. (Tokyo) 1967, 62:746-755.
32. Green W.L. Inhibition of thyroidal iodotyrosine deiodination by tyrosine analogues. Endocrinology 1968, 83:336-346.
33. Green M.A., Grimm Y. Changes in thyroid secretion produced by inhibition of iodotyrosine deiodinase. Endocrinology 1968, 83:405-410.
34. Rosenberg I.N., Goswami A. Purification and characterization of a flavoprotein from bovine thyroid with iodotyrosine deiodinase activity. J. Biol. Chem. 1979, 254:12318-12325.
35. Thomas S., McTamney P.M., Adler J.M., LaRonde-LeBlanc N., Rokita S.E. Crystal structure of iodotyrosine deiodinase, a novel flavoprotein responsible for iodide salvage in thyroid glands. J. Biol. Chem. 2009, 284:19659-19667.
36. Goswami A., Rosenberg I.N. Characterization of a flavoprotein iodotyrosine deiodinase from bovine thyroid. J. Biol. Chem. 1979, 254:12326-12330.
37. Goswami A., Rosenberg I.N. Ferredoxin and ferredoxin reductase activities in bovine thyroid. Possible relationship to iodotyrosine deiodinase. J. Biol. Chem. 1981, 256:893-899.
38. Massey V. The chemical and biological versatility of riboflavin. Biochem. Soc. Trans. 2000, 28:283-296.
39. De Colibus L., Mattevi A. New frontiers in structural flavoenzymology. Curr. Opin. Struct. Biol. 2006, 16:722-728.
40. Joosten V., van Berkel W.J.H. Flavoenzymes. Curr. Opin. Chem. Biol. 2007, 11:195-202.
41. Mansoorabadi S.O., Thibodeaux C.J., Liu H.-w. The diverse roles of flavin coenzymes - nature's most versatile thespians. J. Org. Chem. 2007, 72:6329-6342.
42. Barkay T., Miller S.M., Summers A.O. Bacterial mercury resistance from atoms to ecosystems. FEMS Microbiol. Rev. 2003, 27:355-384.
43. van Pée K.-H., Patallo E.P. Flavin-dependent halogenases involved in secondary metabolism in bacteria. Appl. Microbiol. Biotechnol. 2006, 70:631-641.
44. French A.L., Hoopingarner R.A. Dechlorination of DDT by membranes isolated from Escherichia coli. J. Econ. Entomol. 1970, 63:756-759.
45. Suzuki T., Kasia N. Generation of optically active glycerol derivatives by microbial resolution or development of useful synthetic units for pharmaceuticals. Trends Glycosci. Glycotechnol. 2003, 15:329-349.
46. Dehalogenation: Microbial Processes and Environmental Applications 2003, 520. Kluwer Academic Publishers, Boston. M.M. Häggblom, I.D. Bossert (Eds.).
47. Kunishima M., Friedman J.E., Rokita S.E. Transition-state stabilization by a mammalian reductive dehalogenase. J. Am. Chem. Soc. 1999, 121:4722-4723.
48. Copley S.D. Aromatic dehalogenases: insights into structures, mechanisms, and evolutionary origins. Dehalogenation: Microbial Processes and Environmental Applications 2003, 227-259. Kluwer Academic Publishers, Boston. M.M. Häggblom, I.D. Bossert (Eds.).
49. Warner J.R., Copley S.D. Pre-steady-state kinetic studies of the reductive dehalogenation catalyzed by tetrachlorohydroquinone dehalogenase. Biochemistry 2007, 46:13211-13222.
50. Rosenberg I.N. Purification of iodotyrosine from bovine thyroid. Metabolism 1970, 19:785-798.
51. Goswami A., Rosenberg I.N. Studies on a soluble thyroid iodotyrosine deiodinase: activation by NADPH and electron carriers. Endocrinology 1977, 101:331-341.
52. Poole L.B., Claiborne A. The non-flavin redox center of the streptococcal NADH peroxidase. II. Evidence for a stabilized cysteine-sulfenic acid. J. Biol. Chem. 1989, 264:12330-12338.
53. Watson J.A., McTamney P.M., Adler J.M., Rokita S.E. Flavoprotein iodotyrosine deiodinase functions without cysteine residues. ChemBioChem 2008, 9:504-506.
54. J.E. Friedman, Purification and characterization of iodotyrosine deiodinase, Ph.D. Department of Chemistry and Biochemistry, University of Maryland, College Park, 2001, p. 159.
55. Moreno J.C., Pauws E., van Kampen A.H.C., Jedlicková M., de Vijlder J.J.M., Ris-Stalpers C. Cloning of tissue-specific genes using serial analysis of gene expression and a novel computation subtraction approach. Genomics 2001, 75:70-76.
56. Moreno J.C., Keijser R., Aarraas S., de Vijlder J.J.M., Ris-Stalpers C. Cloning and characterization of a novel thyroidal gene encoding proteins with a conserved nitroreductase domain. J. Endocrinol. Invest. 2002, 25(Suppl. 7):23.
57. Tanner J.J., Lei B., Tu S.C., Krause K.L. Flavin reductase P: structure of a dimeric enzyme that reduces flavin. Biochemistry 1996, 35:13531-13539.
58. Parkinson G.N., Skelly J.V., Neidle S. Crystal structure of FMN-dependent nitroreductase from Escherichia coli B: a prodrug-activating enzyme. J. Med. Chem. 2000, 43:3624-3631.
59. J.A. Watson Jr., Insight into the structure and mechanism of iodotyrosine deiodinase, the first mammalian member of the NADH oxidase/flavin reductase superfamily, Ph.D., Department of Chemistry and Biochemistry, University of Maryland, College Park, 2006, p. 91.
60. Gnidehou S., Lacriox L.S., Sezan A., Ohayon R., Noël-Hudson M.-S., Morand S., Francon J., Courtin F., Virion A., Dupuy C. Cloning and characterization of a novel isoform of iodotyrosine dehalogenase 1 (DEHAL1) DEHAL1C from human thyroid: comparisons with DEHAL1 and DEHAL1B. Thyroid 2006, 16:715-724.
61. Fraaije M.W., Mattevi A. Flavoenzymes: diverse catalysts with recurrent features. Trends Biochem. Sci. 2000, 25:126-132.
62. Lyubimov A.Y., Lario P.I., Moustafa I., Vrielink A. Atomic resolution crystallography reveals how changes in pH shape the protein microenvironment. Nat. Chem. Biol. 2006, 2:259-264.
63. Legrand Y.-M., Gray M., Cooke G., Rotello V.M. Model systems for flavoenzyme activity: relationships between cofactor structure, binding and redox properties. J. Am. Chem. Soc. 2003, 125:15789-15795.
64. McTamney P.M., Rokita S.E. A mammalian reductive deiodinase has broad power to dehalogenate chlorinated and brominated substrates. J. Am. Chem. Soc. 2009, 131:14212-14213.
65. Peterson F.J., Mason R.P., Hovsepian J., Holtzman J.L. Oxygen-sensitive and -insensitive nitroreduction by Escherichia coli and rat hepatic microsomes. J. Biol. Chem. 1979, 254:4009-4014.
66. 12. Nature 2007, 446:449-453.
67. Moreno J.C. Identification of novel genes involved in congenital hypothyroidism using serial analysis of gene expression. Horm. Res. 2003, 3:96-102.
68. Wu W., Chen Y., d'Avignon A., Hazen S.L. 3-Bromotyrosine and 3,5-dibromotyrosine are major products of protein oxidation by eosinophil peroxidase: potential markers for eosinophil-dependent tissue injury in vivo. Biochemistry 1999, 38:3538-3548.
69. Buss I.H., Senthilmohan R., Darlow B.A., Mogridge N., Kettle A.J., Winterbourn C.C. 3-Chlorotyrosine as a marker of protein damage by myeloperoxidase in tracheal aspirates from preterm infants: association with adverse respiratory outcome. Pediatr. Res. 2003, 53:455-462.
70. Pattison D.I., Hawkins C.L., Davies M.J. What are the plasma targets of the oxidant hypochlorous acid? A kinetic modeling approach. Chem. Res. Toxicol. 2009, 22:807-817.
71. Wu W., Samoszuk M.K.C., Comhair S.A.A., Thomassen M.J., Farver C.F., Dweik R.A., Kavuru M.S., Erzurum S.C., Hazen S.L. Eosinophils generate brominating oxidants in allergen-induced asthma. J. Clin. Invest. 2000, 105:1455-1463.
72. Mani A.R., Ippolito S., Moreno J.C., Visser T.J., Moore K.P. The metabolism and dechlorination of chlorotyrosine in vivo. J. Biol. Chem. 2007, 282:29114-29121.